Lactoferrin Versus Ferrous Sulfate in Management of Iron Deficiency Anemia Among Female Medical Ain Shams Students
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Management of iron deficiency anemia incidence by using lab measures include iron profile
研究概览
简要总结
This study aims to compare the efficacy of lactoferrin versus iron supplementation versus two combined supplementation on iron deficiency anemia in female medical Ain Shams students by using iron profile.
详细描述
Iron, an essential element for cell growth and proliferation, is a component of fundamental processes such as DNA replication and energy production. However, iron can also be toxic when present in excess for its capacity to donate electrons to oxygen, thus causing the generation of reactive oxygen species (ROS), such as superoxide anions and hydroxyl radicals
Prevalence of iron deficiency anemia is roughly 38% of pregnant women, 29% of non-pregnant women and 29% of all women of reproductive age have anemia globally
Human lactoferrin (hLf), an 80-kDa multifunctional iron-binding cationic glycoprotein, is constitutively secreted by exocrine glands and by neutrophils during inflammation. hLf is recognized as a key element in the host immune defense system
Bovine Lf (bLf), which shares high sequence homology with the human protein, is also a multifunctional glycoprotein with identical antibacterial, antifungal, antiviral, antiparasitic, anti-inflammatory, and immunomodulatory activities of hLf Lactoferrin is synthesized by exocrine glands and neutrophils under conditions of inflammation and at site of infection through its iron binding and formation of reactive oxygen species physiological transport of iron from tissue to circulation, thus curing iron deficiency and iron deficiency anemia
A study done for pregnant women showed an increase of total serum iron in all bovin lactoferrin treated women.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 19 Years 至 29 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •female student with iron deficiency anemia
排除标准
- •clinical diagnosis of chronic disease as DM, Malabsorption disease Celiac, blood disease as thalassemia, or haemoglobinopathy
- •Intervention:
- •Study participants will be divided into 3 groups; Group 1: 35 participants will be supplemented with iron salt 324 mg (66 mg of elemental iron) orally three time per day before meal for one month Group 2: 35 participants will be supplemented with LF sachet 100 mg twice per day before meal for period of one month.
- •Group 3: 35 participants will be supplemented with combined iron salt 324 mg (66 mg of elemental iron) orally three time per day before meal for one month, and LF sachet 100 mg twice per day before meal for period of one month.
研究组 & 干预措施
Lactoferrin in iron deficiency anemia
lactoferrin ( pravotin) 100mg twice daily
干预措施: Lactoferrin (Drug)
Ferrous sulfate in iron deficiency anemia
ferrous sulphate (hemojet)
干预措施: Ferrous sulfate (Drug)
Lactoferrin and ferrous sulfate in iron deficiency anemia
Lactoferrin 100 mg twice daily and ferrous sulfate
干预措施: Lactoferrin (Drug)
Lactoferrin and ferrous sulfate in iron deficiency anemia
Lactoferrin 100 mg twice daily and ferrous sulfate
干预措施: Ferrous sulfate (Drug)
结局指标
主要结局
Management of iron deficiency anemia incidence by using lab measures include iron profile
时间窗: One month
Management of iron deficiency anemia
次要结局
未报告次要终点
研究者
yasmin gamal el gendy
Yasmin gamel elgendy clinical professor
Ain Shams University
